Histopathologic determinants of regional lymph node metastasis in early colorectal cancer

Cancer

Volumn 112, Issue 4, 2008, Pages 924-933

  Ishikawa, Yukio ^a   Akishima Fukasawa, Yuri ^b   Ito, Kinji ^a   Akasaka, Yoshikiyo ^a   Yokoo, Tomoko ^a   Ishii, Toshiharu ^a   Yamazaki, Kazuto ^c   Shimokawa, Reiko ^d   Suzuki, Takahiro ^e   Fujiwara, Mieko ^e   Kuroda, Yoshikazu ^f   Ichinose, Akihiro ^f   Kiguchi, Hideko ^g   Ogata, Kentaro ^h   Niino, Hitoshi ⁱ   Ebihara, Yoshiro ^a,j  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c SAISEIKAI CENTRAL HOSPITAL   (Japan)

^d Omori Red Cross Hospital

^e ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^f KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g Saiseikai Kanagawa ken Hospital   (Japan)

^h KAWASAKI MUNICIPAL HOSPITAL   (Japan)

ⁱ NATIONAL HOSPITAL ORGANIZATION YOKOHAMA MEDICAL CENTER   (Japan)

^j Toda Chuo General Hospital   (Japan)

more..

Author keywords

Budding; Cell adhesion molecules; Early colorectal cancer; Lymphatic endothelial hyaluronan receptor 1 antibody; Lymphatic invasion

Indexed keywords

BETA CATENIN; CELL RECEPTOR; CLAUDIN 3; CLAUDIN 4; CYTOKERATIN; LYMPHATIC ENDOTHELIAL HYALURONAN RECEPTOR 1; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER INVASION; CANCER PATIENT; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UNIVARIATE ANALYSIS;

AGED; ANALYSIS OF VARIANCE; BETA CATENIN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LYMPHATIC METASTASIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; VESICULAR TRANSPORT PROTEINS;

EID: 39049151426     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23248     Document Type: Article

References (41)

1. Sobin LH, Whittekind C, eds. TNM Classification of Malignant Tumors, 6th ed. New York, NY: John Wiley & Sons; 2002.
2. Fenoglio CM, Pascal RR. Colorectal adenomas and cancer - pathologic relationships. Cancer. 1982;50:2601-2608.
3. Morson BC, Whiteway JE, Jones EA, Macrae FA, Williams CB. Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. Gut. 1984;25:437-444.
4. Okabe S, Shia J, Nash G, et al. Lymph node metastasis in T1 adenocarcinoma of the colon and rectum. J Gastrointest Surg. 2004;8:1032-1040.
5. Kawamura YJ, Sakuragi M, Togashi K, Okada M, Nagai H, Konishi F. Distribution of lymph node metastasis in T1 sigmoid colon carcinoma: should we ligate the inferior mesenteric artery? Scand J Gastroenterol. 2005;40:858-861.
6. Banerji S, Ni J, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol. 1999;22:789-801.
7. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol. 2002;15:434-440.
8. Akishima Y, Ito K, Zhang L, et al. Immunohistochemical detection of human small lymphatic vessels under normal and pathological conditions using the LYVE-1 antibody. Virchows Arch. 2004;444:153-157.
9. Fujimoto A, Ishikawa Y, Akishima-Fukasawa Y, et al. Significance of lymphatic invasion on regional lymph node metastasis in early gastric cancer using LYVE-1 immunohistochemical analysis. Am J Clin Pathol. 2007;127:82-88.
10. Delektorskaya W, Perevoshehikov AG, Golovkov DA, Kushlinskii NE. Expression of E-cadherin, β-catenin, and CD-44v6 cell adhesion molecules in primary tumors and metastasis of colorectal adenocarcinoma. Bull Exp Biol Med. 2005;139:706-710.
11. de Oliveira SS, de Oliveira IM, De Souza W, Morgado-Diaz JA. Claudins upregulation in human colorectal cancer. FEBS Lett. 2005;579:6179-6185.
12. Dhawan P, Singh AB, Deane NG, et al. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest. 2005;115:1765-1776.
13. Resnick MB, Gavilanez M, Newton E, et al. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation. Hum Pathol. 2005,36:886-892.
14. Shimoda T, Ikegami M, Fujisaki J, Matsui T, Aizawa S, Ishikawa E. Early colorectal carcinoma with special reference to its development de novo. Cancer. 1989;64:1138-1146.
15. Hamilton SR, Aaltonen LA. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC Press; 2000.
16. Morodomi T, Isomoto H, Shirouzu K, Kakegawa K, Irie K, Morimatsu M. An index for estimating the probability of lymph node metastasis in rectal cancers - lymph node metastasis and the histopathology of activity invasive regions of cancer. Cancer. 1989;63:539-543.
17. Haggitt RC, Glotzbach RE, Soffer EE, et al. Prognostic factors on colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology. 1985;89:328-336.
18. Minamoto T, Mai M, Ogino T, et al. Early invasive colorectal carcinomas metastatic to the lymph node with attention to their nonpolypoid development. Am J Gastroenterol. 1993;88:1035-1039.
19. Ueno H, Mochizuki H, Hashiguchi Y, et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology. 2004;127:385-394.
20. Sakuragi M, Togashi K, Konishi F, et al. Predictive factors for lymph node metastasis in T1 stage colorectal carcinoma. Dis Colon Rectum. 2003;46:1626-1632.
21. Bayer S, Saxena R, Emir B, Salem RR. Venous invasion may predict lymph node metastasis in early resected cancer. Eur J Surg Oncol. 2002;28:413-417.
22. Gannon B. The vasculature and lymphatic drainage. In: Whiteheaed R, ed. Gastrointestinal and Oesophageal Pathology. London, United Kingdom: Churchill Livingstone; 1989;117-160.
23. Ono S, Sakamoto M, Ino Y, et al. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis. Cancer. 1996;78:1179-1186.
24. Suzuki A, Nagasako K, Fujimori T, Ono Y, Suzuki S, Hayashi N. Clinicopathological evaluation of the trend toward histologically poor differentiation with submucosal invasion in superficial early colorectal adenocarcinomas. J Gastroenterol. 2000;35:832-839.
25. Hase K, Shatney C, Johnson D, Trollope M, Vierra M. Prognostic value of tumor "budding" in patients with colorectal cancer. Dis Colon Rectum. 1993;36:627-635.
26. Okuyama T, Oya M, Ishikawa H. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma. Dis Colon Rectum. 2002;45:628-634.
27. Meguerditchian AN, Bairati I, Lagace R, Harel F, Kibrite A. Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma. Am J Surg. 2005;189:707-713.
28. Nivatrongs S, Rojanasakul A, Reiman HM, et al. The risk of lymph node metastasis in colorectal polyps with invasive adenocarcinoma. Dis Colon Rectum. 1991;34:323-328.
29. Walgenbach-Bruenagel G, Tolba RH, Varnai AD, Bollmann M, Hirner A, Walgenbach KJ. Detection of lymphatic invasion in early stage primary colorectal cancer with the monoclonal antibody D2-40. Eur Surg Res. 2006;38:438-444.
30. Omachi T, Kawai Y, Mizuno R, et al. Immunohistochemical demonstration of proliferating lymphatic vessels in colorectal carcinoma and its clinicopathological significance. Cancer Lett. 2007;246:167-172.
31. Bhalla R, Siddiqui MT, Mandich D, et al. Diagnostic utility of D2-40 and podoplanin in effusion cell blocks. Diagn Cytopathol. 2007;35:342-347.
32. Marks A, Sutherland DR, Bailey D, et al. Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br J Cancer. 1999;80:569-578.
33. Soh S, Ishii T, Sato E, Akishima Y, Ito K, Baba S. Topographic distribution of lymphatic vessels in the normal human prostate. Prostate. 2005;63:330-335.
34. Birchmeier W, Weidner KM, Hulsken J, Behrens J. Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas. Semin Cancer Biol. 1993;4:231-239.
35. Ponta H, Hoffman M, Herrlich P. Recent advances in the genetics of metastasis. Eur J Cancer. 1994;13:1995-2001.
36. Tanaka N, Odajima T, Ogi K, Ikeda T, Satoh M. Expression of E-cadherin, α-catenin, and β-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. Br J Cancer. 2003;89:557-563.
37. Kase S, Sugio K, Yamazaki K, Okamoto T, Yano T, Sugimachi K. Expression of E-cadherin and β-catenin in human non-small cell lung cancer and the clinical significance. Clin Cancer Res. 2000;6:4789-4796.
38. Michl P, Barth C, Buchholz M, et al. Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res. 2003;63:6265-6227.
39. Soini Y, Tommola S, Helin H, Martikainen P. Claudins 1, 3, 4, and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype. Virchows Arch. 2006;448:52-58.
40. Agarwal R, D'Souza T, Morin PJ. Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res. 2005;65:7378-7385.
41. Pan XY, Wang B, Che YC, Weng ZP, Dai HY, Peng W. Expression of claudin-3 and claudin-4 in normal, hyperplastic, and malignant endometrial tissue. Int J Gynecol Cancer. 2007;17:233-241.